NasdaqGM - Nasdaq Real Time Price USD
ArriVent BioPharma, Inc. (AVBP)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:02 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
86,205.00
74,590.00
36,906.00
Operating Income
-86,205.00
-74,590.00
-36,906.00
Net Non Operating Interest Income Expense
11,320.00
5,257.00
--
Pretax Income
-74,885.00
-69,333.00
-36,906.00
Net Income Common Stockholders
-74,885.00
-69,333.00
-36,906.00
Diluted NI Available to Com Stockholders
-74,885.00
-69,333.00
-36,906.00
Basic EPS
-2.23
-2.17
-1.15
Diluted EPS
-2.23
-2.17
-1.15
Basic Average Shares
33,509.09
31,956.66
31,956.66
Diluted Average Shares
33,509.09
31,956.66
31,956.66
Total Operating Income as Reported
-86,205.00
-74,590.00
-36,906.00
Total Expenses
86,205.00
74,590.00
36,906.00
Net Income from Continuing & Discontinued Operation
-74,885.00
-69,333.00
-36,906.00
Normalized Income
-74,885.00
-69,333.00
-36,906.00
Interest Income
11,320.00
5,257.00
--
Net Interest Income
11,320.00
5,257.00
--
EBIT
-86,205.00
-74,590.00
-36,906.00
EBITDA
-86,205.00
-74,590.00
-36,906.00
Net Income from Continuing Operation Net Minority Interest
-74,885.00
-69,333.00
-36,906.00
Normalized EBITDA
-86,205.00
-74,590.00
-36,906.00
12/31/2022 - 1/26/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGON CG Oncology, Inc.
36.44
-0.87%
ANRO Alto Neuroscience, Inc.
14.43
+1.12%
ALMS Alumis Inc.
12.03
+8.18%
ACRV Acrivon Therapeutics, Inc.
8.25
+4.83%
MGX Metagenomi, Inc.
1.9600
-1.51%
BCAX Bicara Therapeutics Inc.
21.96
+7.44%
PHVS Pharvaris N.V.
21.20
-0.24%
PEPG PepGen Inc.
8.94
+0.79%
MBX MBX Biosciences, Inc.
24.07
+3.93%
APGE Apogee Therapeutics, Inc.
53.53
-4.80%